The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 01, 2024
Filed:
Jun. 22, 2021
Applicant:
Crown Laboratories, Inc., Johnston City, TN (US);
Inventors:
Thomas M. Hitchcock, Dallas, TX (US);
Sasima Phadungpojna, Bristol, TN (US);
Matthew D. Stephens, Kingsport, TN (US);
Mun Su Rhee, Johnson City, TN (US);
Assignee:
CROWN LABORATORIES, INC., Johnson City, TN (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/99 (2017.01); A61K 8/02 (2006.01); A61K 8/04 (2006.01); A61K 8/19 (2006.01); A61K 8/34 (2006.01); A61K 8/37 (2006.01); A61K 8/67 (2006.01); A61K 8/73 (2006.01); A61K 8/88 (2006.01); A61K 8/92 (2006.01); A61K 8/9789 (2017.01); A61K 9/06 (2006.01); A61K 9/19 (2006.01); A61K 31/07 (2006.01); A61K 35/741 (2015.01); A61K 47/14 (2017.01); A61K 47/34 (2017.01); A61K 47/44 (2017.01); A61K 47/46 (2006.01); A61Q 19/00 (2006.01);
U.S. Cl.
CPC ...
A61K 8/99 (2013.01); A61K 8/022 (2013.01); A61K 8/042 (2013.01); A61K 8/19 (2013.01); A61K 8/34 (2013.01); A61K 8/37 (2013.01); A61K 8/671 (2013.01); A61K 8/735 (2013.01); A61K 8/88 (2013.01); A61K 8/922 (2013.01); A61K 8/9789 (2017.08); A61K 9/06 (2013.01); A61K 9/19 (2013.01); A61K 31/07 (2013.01); A61K 35/741 (2013.01); A61K 47/14 (2013.01); A61K 47/34 (2013.01); A61K 47/44 (2013.01); A61K 47/46 (2013.01); A61Q 19/00 (2013.01); A61K 2800/524 (2013.01); A61K 2800/594 (2013.01);
Abstract
Described herein are dermatological compositions, formulations containing wild type or genetically modifiedbacteria and methods for use thereof of skin. The cosmetic and therapeutic formulations described herein can be used as cosmetic daily skin treatments or for treating skin inflammation or disorders including acne, psoriasis, rosacea, dermatitis, or eczema.